Rate Control Is a Better Initial Treatment for Patients With Atrial Fibrillation and Heart Failure : Rhythm Control vs. Rate Control : Which Is Better in the Management of Atrial Fibrillation? (Rate-Side)
スポンサーリンク
概要
- 論文の詳細を見る
Congestive heart failure (CHF) and atrial fibrillation (AF) often coexist, and each increase the morbidity and mortality associated with the other. Until now, many studies have reported that a strategy of rate control, in combination with anticoagulation in patients at risk of thromboembolic events, appears to be at least equivalent to a strategy of maintaining sinus rhythm with currently available pharmacological therapeutic options. As compared to rhythm control therapy, rate control treatment is simple and relatively easy. Therefore, pharmacological rate control should be considered initially in patients with AF associated with CHF. However, cardiac symptoms associated with AF may continue after achieving reasonable ventricular rate control. Either pharmacological or non-pharmacological rhythm control needs to be considered at that time. Amiodarone is the only recommended antiarrhythmic drug in the recent therapeutic guidelines for CHF, and can be used for both rhythm and rate control of AF. However, there is no question that some patients require early non-pharmacological rhythm control instead of long-lasting rate control. Catheter ablation (CA) can be applicable even in AF associated with CHF, but the results of CA are closely associated with the clinical and electrophysiological characteristics in each patient, as well as with the experience with this procedure in each institution. Indications for and the appropriate period of CA need to be carefully examined in each individual. (Circ J 2011; 75: 970 - 978)
- 2011-03-25
著者
-
Chinushi Masaomi
School Of Health Science Niigata University School Of Medicine
-
IIJIMA Kenichi
First Department of Internal Medicine, Niigata University School of Medicine
-
Iijima Kenichi
First Department Of Internal Medicine Niigata University School Of Medicine
関連論文
- PJ-004 Clinical and ECG Characteristics as a Predictor of Recurrence of Ventricular Tachyarrhythmia (VTA) in Patients with Hypertrophic Cardiomyopathy (HCM)(PJ001,Arrhythmia, Others (Clinical/Pathophysiology) 1 (A),Poster Session (Japanese),The 73rd Annua
- Japanese Randomized Trial for Investigation of a Combined Therapy of Amiodarone and Implantable Cardioverter Defibrillator in Patients With Ventricular Tachycardia and Fibrillation : The Nippon ICD Plus Pharmacologic Option Necessity (NIPPON) Study Design
- Clinical Characteristics, Treatment, and Outcome of Tachycardia Induced Cardiomyopathy
- Primary Concerns during Daily Life in Patients with ICD and their Families (Role of ICD Discharge for Quality of Life)
- Comparison of triggering modes and therapeutic effect of nicorandil for ventricular tachyarrhythmia in canine models of LQT2 and LQT3
- Tridimensional analysis of onset mode and arrhythmogenesis of discordant QT/T alternans in long QT syndrome
- Significance of Early Onset and Progressive Increase of Activation Delay During Premature Stimulation in Brugada Syndrome
- PJ-692 Role of Faster Pacing and Magnesium (Mg) for the Treatment of Torsade de pointes (Tdp) Associated with Intravenous Amiodarone Administration(PJ116,Ventricular Arrhythmia (Clinical/Pathophysiology) (A),Poster Session (Japanese),The 73rd Annual Scien
- PJ-688 The Abnormality of QT/RR Relationship in Brugada Syndrome and Idiopathic Ventricular Fibrillation without Prominent J-wave(PJ116,Ventricular Arrhythmia (Clinical/Pathophysiology) (A),Poster Session (Japanese),The 73rd Annual Scientific Meeting of T
- PJ-555 Distribution of Defibrillation Threshold (DFT) in Patients Treated with Implantable Cardioverter-Defibrillators (ICD) : Incidence and Characteristics of High DFT Patients(PJ093,Ventricular Arrhythmia (Clinical/Diagnosis/Treatment) 2 (A),Poster Sess